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Introduction: Rabson-Mendenhall Syndrome (RMS) is a rare form of severe insulin resistance due to a recessive
mutation of the insulin receptor. Associated manifestations include facial dysmorphism, skin abnormalities, and
renal anomalies.
Case presentation: We report a case of a 13 year old African female with RMS, severe insulin resistance, and a
cluster of renal pathologies including nephromegaly, nephrolithiasis, hydronephrosis, and medullary sponge kidney.
Conclusion: This is the first case of severe insulin resistance associated with the collection of renal conditions
described. We postulate that renal conditions present in RMS may be under recognised, and recommend screening
for the above conditions. This case adds to the scarce body of literature of associated renal manifestations with
RMS, including medullary sponge kidney, across the spectrum of insulin resistance.
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Rabson-Mendenhall Syndrome (RMS) is due to an auto-
somal recessive mutation of the insulin receptor, with con-
sequential variable insulin resistance. In terms of severity,
RMS occupies the intermediate spectrum of the conti-
nuum of insulin resistance, being flanked by the milder
phenotype of Type A insulin resistance, and on the other
side by the more severe condition of Leprechaunism (also
known as Donohue Syndrome) [1].The manifestations of
severe insulin resistance include hyperinsulinaemia, post
prandial hyperglycemia, paradoxical fasting hypoglycaemia,
acanthosis nigricans, lipoatrophy, growth retardation, and
external genital enlargement. The characteristic facial fea-
tures include dysmorphic coarse facies with a prognathic
jawline, fissured tongue, with dental precocity, hyperplasia
and caries. Cutaneous findings include hypertrichosis, skin
tags, lichenified skin, and onychauxis. A protuberant ab-
domen is often described [2,3]. Early published cases com-* Correspondence: ben.wheeler@otago.ac.nz
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reproduction in any medium, provided the ormonly reported pineal dysfunction and hypertrophy on
autopsy [4,5].
A variety of kidney manifestations have been reported
in RMS, including nephrocalcinosis with or without
hydronephrosis, and nephromegaly [2,3]. Two cases have
been published of associated Medullary Sponge Kidney
(MSK) [6,7]. Uncertainty remains as to whether these
are independent of, or characteristic features, of RMS.
We present the first case of RMS with severe insulin
resistance, and all four previously described kidney manifes-
tations: nephrocalcinosis, hydronephrosis, nephromegaly,
and radiologically confirmed severe MSK.
Case presentation
A five year old female presented, shortly after migration
from Africa, with chronic scalp infection and otitis media.
She was noted to have symptomatic hyperglycaemia, with
a history dating back possibly to two years of age. She was
observed to have several cutaneous and facial features
typical of the RMS phenotype (Figure 1).
Biochemical insulin resistance was documented, with
elevated fasting plasma insulin level of 1836 pmol/L
(normal laboratory value: 9–80 pmol/L). At age six, dia-
betes mellitus was diagnosed with the classical pattern
of daytime postprandial hyperglycaemia, but paradoxicalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Clinical manifestations of Rabson Mendenhall Syndrome. A = Acanthosis Nigricans, B = Acrochordons with protruberant abdomen
and lipohypertrophy, C = hypertrichosis, D = Dental dysplasia with caries (younger age), E = Fungiform Papillae of Tongue (younger age),
F = Triangular Facies.
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strated a homozygote mutation at position 119 of the ma-
ture alpha subunit of the insulin receptor, but a normal
beta subunit. She is of African ethnicity, and was born of a
consanguineous union between first cousins. There is no
other family history of insulin resistance.
Her diabetes was initially managed with Metformin
(currently 3 grams/day) followed by a brief trial of added
pioglitazone. She rapidly progressed to insulin, with a
current insulin requirement of 2100 units per day (>50units/kg/day). Despite this, her glycaemic control remains
suboptimal, with an HbA1c of 75 mmol/mol (9%). She has
a current weight of 36 kg, height of 148 cm (Z score −1.1)
and BMI of 16.6 kg/m2.
Enlarged kidneys were noted from six years of age.
Ultrasonography revealed persistent renal sizes greater
than two standard deviations for her age (11 cm diameter
left, 10 cm diameter right), with poorly defined medullary
renal pyramids, loss of normal cortico-medullary differen-
tiation, and a mildly dilated right collecting system. There
Figure 2 Renal manifestations on CT abdomen. Bilateral
nephromegaly (Greater than 2 standard deviation for age), and
nephrocalcinosis (in red box).
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was identified, and appropriate biochemical studies were
done, revealing hypercalciuria (Table 1). At age of eight
years a mercaptoacetyl triglycine MAG 3 renogram demon-
strated normal function bilaterally with an effective renal
plasma flow (ERPF) from right kidney of 379 mL/min and
left kidney of 404 mL/min (normal ERPF>300 ml/min).
At the age of eleven years she presented with recurrent
left flank pain, associated microscopic haematuria, and al-
buminuria on dipstick examination. There were no features
to suggest an infective or traumatic aetiology to her symp-
toms. She was pre-pubertal. Ultrasonography showed a
right kidney of 12.3 cm, left kidney of 13.2 cm, with mul-
tiple bilateral renal calculi, the largest 10mm in diameter.
The right renal pelvis was dilated (1.2 cm), and a simple 10
mm cyst seen in the left kidney. The bladder was normal.
A CT urogram revealed a 2 mm calcification seen to the
left of the true renal pelvis, suggestive of an intraluminal
ureteric calculus. Intravenous pyelogram further demon-
strated paintbrush-like appearances of the renal pyramids,
consistent with MSK (Figure 2). The patient had the most
severe form of MSK, grade 4, with involvement of all the
calyces in both kidneys [8].
Her nephrocalcinosis was actively managed by optimi-
sing fluid intake and a trial of thiazide diuretic. Treatment
was ceased at 3 months, at the request of the family as she
remained asymptomatic from her nephrocalcinosis. No
further acute episodes of nephrocalcinosis or pain have
recurred.
Conclusions
To our knowledge, this is the first case to describe this full
constellation of renal manifestations in association with
severe insulin resistance and Rabson-Mendenhall syn-
drome. Given that ours is the third case showing an asso-
ciation of MSK with RMS, we suggest that MSK be






Parathyroid Hormone 28.3 p
25OH Vitamin D 40 nm
Creatinine 30 um
Urine:
24 hour urine calcium excretion 8.66 m
Citrate concentration 5.2 m
Spot urinary cysteine level Nega
Albumin : Creatinine ratio 34.1 minsulin resistance. The first such report is described in
Harris et al., concerning a 10 year old boy with an inciden-
tal finding of MSK during investigation for symptomatic
nephrocalcinosis. The main phenotypic difference between
this case and ours is the severity of insulin resistance, as
the boy required only rosiglitazone and metformin, in con-
trast to our patient, who needed maximal doses of metfor-
min and very high doses of insulin [6].lts Reference Range
mol / L 2.05 – 2.50 mmol / L
mol/L 0.9 – 1.65 mmol/L
mol / L 0.75 – 1.0 mmol / L
g / mL 16 – 87 pg / mL
ol/L 50 – 150 nmol/L
ol/L 50 – 100 umol/L
mol/24 hr 1.25 – 6.25 mmol / 24 hr
mol / L 0.4 – 3.4 mmol / L
tive
g / mmol < 3.6 mg / mmol
Figure 3 Renal Manifestations on intravenous urogram.
A = hydronephrosis, B = Medullary Sponge Kidney (Paint brush
borders in all calyces).
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and radiological finding of MSK and nephrocalcinosis,
with yet unknown aetiology to link these conditions [7].
Bathi et al. describes a 16 years old female with clinical
features of RMS having ultrasonographic evidence of bi-
lateral nephromegaly and hydronephrosis. Unfortunately
no mutational analysis was done, and a request for in-
vestigation to ascertain any feature of MSK was declined
[3]. Other case reports of RMS have either not described
any renal features, or only isolated associations, such as
medullary nephrocalcinosis [9] or palpable kidneys [10].
We propose that these several renal phenotypes are
under-recognised in the RMS population, and we there-
fore recommend screening for these renal conditions,
and especially for nephrocalcinosis.
Furthermore, we demonstrated severe insulin resis-
tance in our patient, with an HbA1c >9% despite a total
daily insulin dose of >2000 IU. Given the association in
this patient, we postulate that there might be a causal
link between hyperinsulinaemia and renal manifesta-
tions. Beckwith Wiedemann Syndrome (BWS), a pae-
diatric disorder of excess growth, may present an
instructive example. Similar renal manifestations, includ-
ing nephromegaly, nephrocalcinosis, hydronephrosis,
and MSK [11], are seen in BWS. 80% of BWS is asso-
ciated with a loss of imprinting of chromosome segment
11p15, which encodes for genes including Insulin-like
Growth Factor 2 (IGF2) [12]. IGF2 is a potent foetal
growth factor, and dysregulation of this hormone can
lead to an overgrowth phenotype [12]. Post-partum,
IGF2 acts on the IGF1 receptor to exert its anabolic
effect. Insulin, which shares homologous structure to
IGFs, can bind to IGF1, inducing similar downstream
effects [13]. Thus, we may hypothesise that the hyperin-
sulinaemia in RMS plays a role in the aetiology of the
various renal pathologies, via the IGF signalling pathway,
although this remains speculative at present [6].In conclusion, to our knowledge, this is the first case of
severe insulin resistance associated with all four renal con-
ditions described, especially with a severe form of MSK.
We postulate a mechanism for these renal conditions in
RMS. These renal manifestations appear to be under
recognised, and screening for the above conditions, in par-
ticular nephrocalcinosis, is recommended.
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